Category: Include on Menu

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) gained 2.4% on Monday after CEO Allen Baharaff issued a shareholder update outlining the company’s strengthened financial footing and progress across several clinical programs. The biopharmaceutical developer — which has broadened its pipeline beyond liver disease to include oncology and cardiometabolic conditions — ended the third quarter with roughly $19.2 million…

SciSparc Ltd. (NASDAQ:SPRC) plunged 15.6% on Monday after announcing that it intends to purchase a portfolio of patents and intellectual property related to several endoscopic technologies — including the MUSE™ system — from Xylo Technologies Ltd. The clinical-stage pharmaceutical company, acting through its majority-owned subsidiary NeuroThera Labs Inc., has entered into a binding term sheet…

Propanc Biopharma Inc (NASDAQ:PPCB) rose 5.4% on Monday after announcing it has applied for a foreign filing license in Spain covering two new provisional patent applications. The patents — which will be formally filed with IP Australia under Propanc’s wholly owned subsidiary, Propanc Pty Ltd — introduce novel approaches for treating therapy-resistant cancers and fibrosis.…

E-Home Household Service Holdings Limited (NASDAQ:EJH) dipped 2% on Monday after revealing plans to acquire Fuzhou Yunding Mutual Chain Information Technology Co., Ltd., a move that follows extensive negotiations and due-diligence work. Fuzhou Yunding operates in the artificial intelligence–driven access control and smart community service space, holding more than 20 authorized IP rights. The company…

Ascent Industries Co. (NASDAQ:ACNT) climbed 8.1% on Monday after revealing that it has won a major new customer program projected to deliver more than $10 million in incremental annualized revenue. The newly secured business equates to roughly 15% growth compared with the company’s trailing twelve-month sales, and management expects margins on the program to come…

Belite Bio Inc ADR (NASDAQ:BLTE) leapt 17.1% in premarket trading Monday after unveiling strong Phase 3 results for Tinlarebant — the first pivotal clinical trial to show efficacy in Stargardt disease, a rare inherited condition that causes progressive vision loss and currently has no approved therapies. The late-stage DRAGON study achieved its main goal, showing…

Cullinan Therapeutics (NASDAQ:CGEM) saw its stock rise 2.9% in Monday’s premarket session after announcing that the U.S. Food and Drug Administration has awarded Fast Track designation to CLN-049, its investigational treatment for relapsed or refractory acute myeloid leukemia (AML). The Cambridge-based biotech said the designation demonstrates both the seriousness of AML and the need for…

Massimo Group (NASDAQ:MAMO) rallied 18% on Monday after unveiling a new treasury initiative that will incorporate Bitcoin into its long-term balance sheet management. The powersports manufacturer said its Board of Directors has formally approved the use of Bitcoin as a treasury reserve asset, and initial purchases have already begun. Massimo said it will report its…

Omeros Corporation (NASDAQ:OMER) surged 12% on Monday after the company confirmed it has officially completed its asset purchase and license agreement with Novo Nordisk for zaltenibart, its clinical-stage MASP-3 inhibitor. The agreement, first unveiled on October 15, delivers an upfront cash payment of $240 million, which Omeros has already received. In total, the company could…

Laser Photonics Corp. (NASDAQ:LASE) saw its stock drop 8.3% in premarket trading on Monday after revealing it had received a non-compliance notice from Nasdaq tied to a delayed quarterly filing. The company said Nasdaq informed it on November 20, 2025, that it was out of compliance with listing standards because it had not submitted its…